HRTX HERON THERAPEUTICS, INC. /DE/: institutional ownership and insider trading
179 funds reported holding $72.3M of HERON THERAPEUTICS, INC. /DE/ in their latest 13F filings; in Q2 2026 funds net sold $9.93M, with 20 new positions and 21 funds selling out; over the last 12 months insiders bought $0 and sold $0 on the open market; over its last four quarters it reported revenue of $151M and net income of −$33.9M.
HRTX revenue and earnings
- Quarter ended Jun 30, 2026: revenue $37.7M, net income −$5.49M, EPS -0.03
- Quarter ended Mar 31, 2026: revenue $34.7M, net income −$8.11M, EPS -0.04
- Quarter ended Dec 31, 2025: revenue $40.6M, net income −$2.76M, EPS -0.01
- Quarter ended Sep 30, 2025: revenue $38.2M, net income −$17.5M, EPS -0.10
Famous investors holding HRTX
- Izzy Englander (Millennium Management): $1.74M, 0.0% of the portfolio
- Renaissance Technologies (Renaissance Technologies): $643K, 0.0% of the portfolio
- Two Sigma (Two Sigma Investments): $114K, 0.0% of the portfolio
- D. E. Shaw (D. E. Shaw & Co.): $51.4K, 0.0% of the portfolio
- Ken Griffin (Citadel Advisors): $20.1K, 0.0% of the portfolio
Largest institutional holders of HRTX
- Rubric Capital Management LP — $12.8M
- VANGUARD GROUP INC — $12.8M
- Clearline Capital LP — $4.86M
- BlackRock, Inc. (BLK) — $4.50M
- Velan Capital Investment Management LP — $3.74M
- VANGUARD CAPITAL MANAGEMENT LLC — $3.32M
- Tejara Capital Ltd — $2.78M
- TANG CAPITAL MANAGEMENT LLC — $2.67M
- GEODE CAPITAL MANAGEMENT, LLC — $1.82M
- MILLENNIUM MANAGEMENT LLC — $1.74M
Recent HRTX insider trades
- Aug 8, 2025: Morgan Adam bought 1,766,546 shares ($2.65M)
- Aug 8, 2025: Rubric Capital Management LP bought 2,387,225 shares ($3.58M)
5%+ owners
- Rubric Capital Management LP: 15.9% (Schedule 13D/A, filed Oct 17, 2025)
- Clearline Capital LP: 6.7% (Schedule 13G/A, filed Feb 17, 2026)